Source: International Congress 2014 – Acute pulmonary embolism
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
H. Selimoglu Sen, O. Abakay, C. Sezgi, S. Yilmaz, M. Taylan, H. Kaya, A. C. Tanrikulu, A. Abakay (Diyarbakir, Turkey). An overview of thrombolytic treatment for pulmonary embolism: A single center experience. Eur Respir J 2014; 44: Suppl. 58, 2393

Member's Comments

No comment yet.

Related content which might interest you: Rivaroxaban for treatment of venous thromboembolism. A real-life perspective in 103 patients Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Prognosis factors of recurrent pulmonary thromboembolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Long-term screening for pulmonary hypertension after pulmonary embolism Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Do persistent perfusion defects predict late recurrences in pulmonary embolism? Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Pulmonary arterial hypertension – A single-centre experience Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Improving the safety of right heart catheterisation in sickle cell disease Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Comparision of catheter-directed therapy with the systemic thrombolysis for the treatment of acute pulmonary embolism with right ventricular dysfunction Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Warfarin-associated intracranial hemorrhage during anticoagulation therapy Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Epoprostenol dosing by concomitant therapies in the PROSPECT registry Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Alteration of factors associated with coagulation in provoked pulmonary embolism Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Clinical phenotypes in pulmonary emboli identified by cluster analysis Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Early screening for reperfusionand CTEPH after acute pulmonary embolism – Early screening for reperfusion and CTEPH after acutepulmonary embolism Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Nebivolol and pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: pathobiology Year: 2014 Prognostic value of TDI assessment of right ventricular function in patients with acute pulmonary embolism Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014 Is a complete blood cell count useful in determining the prognosis of pulmonary embolism? Source: International Congress 2014 – Acute pulmonary embolism Year: 2014 Immune signatures in pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Single center experience with systematic diagnostic and predictive genetic screening for pulmonary arterial hypertension Source: International Congress 2014 – Pulmonary hypertension: clinical management Year: 2014 Optimization of PH diagnostic process with IVUS during right heart catheterization Source: International Congress 2014 – Chronic thromboembolic pulmonary hypertension Year: 2014 Endothelial-to-mesenchymal transition in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Non-invasive cardiac output assessment in pulmonary hypertension Source: International Congress 2014 – Pulmonary hypertension: right ventricle and basic physiology Year: 2014